MedPath

Intravascular Ultrasound Prediction of Myocardial Size and Coronary Computed Tomography-Derived Ischemic Burden for Coronary Lesion

Active, not recruiting
Conditions
Coronary Artery Disease
Interventions
Other: Intravascular Ultrasound, coronary computed tomography angiography
Registration Number
NCT02845505
Lead Sponsor
Asan Medical Center
Brief Summary

The aims of this study are 1) to identify IVUS determinants of the CAMS-derived myocardial territories subtended to the diseased vessels, 2) to find IVUS determinant for the extent of CAMS-derived myocardial size, and 3) to develop the mathematical model that integrates the IVUS information about myocardial territory and stenosis severity and predicts the extent of CAMS-derived myocardial size.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
500
Inclusion Criteria
  • Age 20years or older
  • Patients who have at least one epicardial coronary artery lesion (including isolated left main disease or side branch) with visually estimated diameter stenosis >50% and take coronary angiography, CT angiography and IVUS
  • Willing and able to provide informed written consent
Read More
Exclusion Criteria
  • In-stent restenosis
  • Bypass graft
  • Suspected coronary spasm even after sufficient nitrate injected
  • Cases in which the IVUS imaging catheter failed to cross the lesion
  • Poor quality IVUS or CT images
  • Visible collateral flow on angiography
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
IVUS-CAMSIntravascular Ultrasound, coronary computed tomography angiographypatients who undergo coronary computed tomography angiography, invasive coronary angiography and IVUS
Primary Outcome Measures
NameTimeMethod
mathematically-predicted ischemic size (by using IVUS parameters) vs. CAMS-derived myocardial size subtended to the stenotic segment1 year
Secondary Outcome Measures
NameTimeMethod
Impact of plaque characteristics (attenuated plaque, plaque rupture, calcification, thrombosis, etc.) assessed by IVUS on the ischemic burden assessed by CAMS1 year
Incidence of MACE comprising death, nonfatal myocardial infarction or target vessel revascularization1 year

Trial Locations

Locations (12)

Hallym University Sacred Heart hospital

🇰🇷

Anyang, Korea, Republic of

Asan Medical Center

🇰🇷

Seoul, Songpa-Gu, Korea, Republic of

Gangneung Asan Hospital

🇰🇷

Gangneung, Korea, Republic of

Hallym University Dongtan Sacred Heart Hospital

🇰🇷

Gyeonggi-do, Korea, Republic of

Chungnam National University Hospital

🇰🇷

Daejeon, Korea, Republic of

Pusan National University Hospital

🇰🇷

Pusan, Korea, Republic of

Inje university Pusan Paik hospital

🇰🇷

Pusan, Korea, Republic of

Kangbuk Samsung Hospital

🇰🇷

Seoul, Korea, Republic of

Kosin University Gospel Hospital

🇰🇷

Pusan, Korea, Republic of

Ulsan University Hospital

🇰🇷

Ulsan, Korea, Republic of

Pusan National University Yangsan Hospital

🇰🇷

Yangsan, Korea, Republic of

Veterans Hospital Medical Center

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath